Reduced-Intensity Regimen Called "New Standard" in Hodgkin's Lymphoma

This trial is clearly going to change practice and, in this select group of patients with early Hodgkin’s disease, shows that we can reduce the intensity of treatment – we can give fewer cycles of chemotherapy and we can give a lesser dose of radiation – and still have a good outcome. We would hope that this would lead to fewer long-term side effects without reducing the efficacy of the treatment.

Andrew McCann, M.B.B.S., is a radiation oncologist based at Auckland (New Zealand) Hospital.